Search
for
Sort by
Research 691–720 of 1000+
- The role of janus kinases in the treatment of autoimmune skin diseases
- Upadacitinib in the treatment of a patient with the triad of atopic dermatitis, vitiligo, and alopecia areata: a case report and literature review
- Upadacitinib for the Treatment of Systemic Immune Co-Morbidity in One Case: Alopecia Areata, Vitiligo, Ankylosing Spondylitis, and Allergic Rhinitis-Asthma – Multifaceted Control
- Dermatologic Comorbidities Associated with Atopic Dermatitis Towards a Shared Therapeutical Approach: A Narrative Review
- Integrated single-cell chromatin and transcriptomic analyses of peripheral immune cells in patients with alopecia areata
- Ritlecitinib: First Approval
- Alopecia areata: a review on diagnosis, immunological etiopathogenesis and treatment options
- Androgen Deprivation Therapy in Prostate Cancer: Focusing on Sexual Side Effects
- The Significance of NOTCH Pathway in the Development of Fibrosis in Systemic Sclerosis
- Analysis of hidradenitis suppurativa–linked mutations in four genes and the effects of PSEN1-P242LfsX11 on cytokine and chemokine expression in macrophages
- Serum level of interleukin-15 in active alopecia areata patients and its relation to age, sex, and disease severity
- Effects of a complex mixture prepared from agrimonia, houttuynia, licorice, peony, and phellodendron on human skin cells
- Role of topical tofacitinib in autoimmune skin disorders: An expert opinion
- Upadacitinib Efficacy for the Treatment of Concomitant Psoriasis and Alopecia Areata
- Estimation of Dehydroepiandrosterone (DHEA) and Tumor Necrosis Factor–Alpha (TNF-α) Levels Women Diagnosed with Polycystic Syndrome
- WISP-1 induced by mechanical stress contributes to fibrosis and hypertrophy of the ligamentum flavum through Hedgehog-Gli1 signaling
- A Bibliometric Analysis of Alopecia Areata Literature over the Past 50 Years.
- Decoding Hyperpigmentation from Biological Mechanisms to Actives with Clinically Proven Topical Efficacy: A Narrative Review
- The PDGF/PDGFR pathway as a drug target
- Updated Treatment for Acne: Targeted Therapy Based on Pathogenesis
- Management of congenital ichthyoses: European guidelines of care, part two
- Imbalance of T‐helper 17 and regulatory T cells in patients with alopecia areata
- The dihydrotestosterone (DHT) hypothesis of prostate cancer and its therapeutic implications
- Advances in the Management of Cutaneous Toxicities of Targeted Therapies
- Toxic shock syndrome: Recent developments in pathogenesis
- Exfoliative cutaneous lupus erythematosus in German shorthaired pointer dogs: disease development, progression and evaluation of three immunomodulatory drugs (ciclosporin, hydroxychloroquine, and adalimumab) in a controlled environment
- Polygonum multiflorum extract support hair growth by elongating anagen phase and abrogating the effect of androgen in cultured human dermal papilla cells
- The concealed side of caspases: beyond a killer of cells
- Madarosis, milphosis, eyelash trichomegaly, and dermatochalasis
- Rice bran mineral extract increases the expression of anagen-related molecules in human dermal papilla through wnt/catenin pathway